PARK7 and Miyoshi myopathy: PARK7 also enhances the metastatic ability of breast cancer and MM by inducing epithelial–mesenchymal transition via suppression of the expression of Krűppel-like transcription factor (KLF) 17 and KLF6 [53,92,93].